Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Schmidt

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
The Journal of Nervous and Mental Disease|May 1, 1996
Personality characteristics and sexual functioning of 188 cross-dressing menG R Brown, T N Wise, P T Costa, et al.
Drug and Alcohol Dependence|June 1, 1994
Condom use rates for specific sexual behaviors among opioid abusers entering treatmentV L King, R K Brooner, G E Bigelow, et al.
The Journal of Clinical Investigation|October 28, 1998
A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infectionS L Silins, S M Cross, K G Krauer, et al.
British Journal of Cancer|January 8, 2009
Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53S C Naumann, W P Roos, E Jöst, et al.
Advances in Cancer Research|August 26, 1998
The labyrinthine ways of cancer immunotherapy--T cell, tumor cell encounter: "how do I lose thee? Let me count the ways"K A Ellem, C W Schmidt, C L Li, et al.
British Journal of Cancer|February 22, 2007
Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destructionJ D Lickliter, J Cox, J McCarron, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
The Journal of Nervous and Mental Disease|May 1, 1996
Personality characteristics and sexual functioning of 188 cross-dressing menG R Brown, T N Wise, P T Costa, et al.
Drug and Alcohol Dependence|June 1, 1994
Condom use rates for specific sexual behaviors among opioid abusers entering treatmentV L King, R K Brooner, G E Bigelow, et al.
The Journal of Clinical Investigation|October 28, 1998
A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infectionS L Silins, S M Cross, K G Krauer, et al.
British Journal of Cancer|January 8, 2009
Temozolomide- and fotemustine-induced apoptosis in human malignant melanoma cells: response related to MGMT, MMR, DSBs, and p53S C Naumann, W P Roos, E Jöst, et al.
Advances in Cancer Research|August 26, 1998
The labyrinthine ways of cancer immunotherapy--T cell, tumor cell encounter: "how do I lose thee? Let me count the ways"K A Ellem, C W Schmidt, C L Li, et al.
British Journal of Cancer|February 22, 2007
Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destructionJ D Lickliter, J Cox, J McCarron, et al.
The Journal of Experimental Medicine|December 1, 1994
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virusV P Argaet, C W Schmidt, S R Burrows, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 1997
A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapyK A Ellem, M G O'Rourke, G R Johnson, et al.
Pageof 12